SHANGHAI PHARMACEUTICALS HOLDINGSHANGHAI PHARMACEUTICALS HOLDINGSHANGHAI PHARMACEUTICALS HOLDING

SHANGHAI PHARMACEUTICALS HOLDING

No trades
See on Supercharts

601607 fundamentals

SHANGHAI PHARMACEUTICALS HOLDING financial statements, including revenue, expenses, profit, and loss

The total revenue of 601607 for the last quarter is 70.02 B CNY, and it's 1.38% higher compared to the previous quarter. The net income of Q3 24 is 1.11 B CNY.

Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: CNY
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth